Sfoglia per RIVISTA
THE ONCOLOGIST
Collezione AOU San Luigi di Orbassano
Items : 12
RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape. in The oncologist / Oncologist. 2023 May 8;28(5):402-413. doi: 10.1093/oncolo/oyac264.
2023
AOU San Luigi di Orbassano
Novello S; Califano R; Reinmuth N; Tamma A; Puri T;
International Survey on Frailty Assessment in Patients with Cancer. in The oncologist / Oncologist. 2022 Oct 1;27(10):e796-e803. doi: 10.1093/oncolo/oyac133.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Garetto L; Maltese G; O'Carroll E; Musolino N; Bambury K; Battisti NML; Haydock MM; Cantale O; Banna GL; Addeo A; Gomes F;
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. in The oncologist / Oncologist. 2022 Oct 1;27(10):e783-e795. doi: 10.1093/oncolo/oyac172.
2022
AOU San Luigi di Orbassano
Barthélémy P; Dorff T; Stirling A; Machiels JP; Bimbatti D; Kilari D; Dumez H; Buttigliero C; van Oort IM; Castro E; Chen HC; Di Santo N; DeAnnuntis L; Healy CG; Scagliotti GV; Mehra N; Fizazi K; de Bono JS;
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study. in The oncologist / Oncologist. 2021 Oct;26(10):e1854-e1861. doi: 10.1002/onco.13851. Epub 2021 Jun 18.
2021
AOU San Luigi di Orbassano
Celio L; Cortinovis D; Cogoni AA; Cavanna L; Martelli O; Carnio S; Collovà E; Bertolini F; Petrelli F; Cassano A; Chiari R; Zanelli F; Pisconti S; Vittimberga I; Letizia A; Misino A; Gernone A; Bonizzoni E; Pilotto S; De Placido S; Bria E;
NGR-hTNF and Doxorubicin as Second-Line Treatment of Patients with Small Cell Lung Cancer. in The oncologist / Oncologist. 2018 Oct;23(10):1133-e112. doi: 10.1634/theoncologist.2018-0292. Epub 2018 Aug 3.
2018
AOU San Luigi di Orbassano
Gregorc V; Cavina R; Novello S; Grossi F; Lazzari C; Capelletto E; Genova C; Salini G; Lambiase A; Santoro A;
Real-world study of everolimus in advanced progressive neuroendocrine tumors. in The oncologist / Oncologist. 2014 Sep;19(9):966-74. doi: 10.1634/theoncologist.2014-0037. Epub 2014 Aug 12.
2014
AOU San Luigi di Orbassano
AO Cuneo
Delle Fave G; Falconi M; Colao A; Berruti A; Appetecchia M; Cartenì G; Campana D; Cassano A; Ambrosio MR; Fontana A; Pusceddu S; Spada F; Funaioli C; Antonuzzo L; Chiara S; Merlano M; Cascinu S; Pastorelli D; Faggiano A; Nobili E; Zaniboni A; Brizzi MP; Nuzzo C; Riccardi F; Tomassetti P; Lugli F; Zatelli MC; Luppi G; de Braud F; et alii...
The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study. in The oncologist / Oncologist. 2012;17(11):1430-8. doi: 10.1634/theoncologist.2012-0142. Epub 2012 Sep 6.
2012
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Tampellini M; Ottone A; Bellini E; Alabiso I; Baratelli C; Bitossi R; Brizzi MP; Ferrero A; Sperti E; Leone F; Miraglia S; Forti L; Bertona E; Ardissone F; Berruti A; Alabiso O; Aglietta M; Scagliotti GV;
Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration. in The oncologist / Oncologist. 2012;17(5):645-52. doi: 10.1634/theoncologist.2011-0448. Epub 2012 Apr 20.
2012
AOU San Luigi di Orbassano
Berruti A; Cook R; Saad F; Buttigliero C; Lipton A; Tampellini M; Lee KA; Coleman RE; Smith MR;
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. in The oncologist / Oncologist. 2011;16(9):1215-27. doi: 10.1634/theoncologist.2011-0098. Epub 2011 Aug 11.
2011
AOU San Luigi di Orbassano
Buttigliero C; Monagheddu C; Petroni P; Saini A; Dogliotti L; Ciccone G; Berruti A;
Targeting angiogenesis with multitargeted tyrosine kinase inhibitors in the treatment of non-small cell lung cancer. in The oncologist / Oncologist. 2010;15(5):436-46. doi: 10.1634/theoncologist.2009-0225. Epub 2010 Apr 28.
2010
AOU San Luigi di Orbassano
Scagliotti G; Govindan R;
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies. in The oncologist / Oncologist. 2009 Mar;14(3):253-63. doi: 10.1634/theoncologist.2008-0232. Epub 2009 Feb 16.
2009
AOU San Luigi di Orbassano
Scagliotti G; Hanna N; Fossella F; Sugarman K; Blatter J; Peterson P; Simms L; Shepherd FA;
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions. in The oncologist / Oncologist. 2008 Nov;13(11):1137-48. doi: 10.1634/theoncologist.2008-0162. Epub 2008 Nov 7.
2008
AOU San Luigi di Orbassano
ASL Torino 5
Berruti A; Brizzi MP; Generali D; Ardine M; Dogliotti L; Bruzzi P; Bottini A;